| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Auris Medical Holding Ltd (NASDAQ: CYTO)
CYTO Technical Analysis
5
| As on 9th Jun 2023 CYTO STOCK Price closed @ 0.77 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.28 & Strong Sell for SHORT-TERM with Stoploss of 1.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYTOSTOCK Price
| Open | 0.73 | Change | Price | % |
| High | 0.78 | 1 Day | 0.03 | 4.05 |
| Low | 0.73 | 1 Week | -0.11 | -12.50 |
| Close | 0.77 | 1 Month | -0.22 | -22.22 |
| Volume | 277000 | 1 Year | -0.52 | -40.31 |
| 52 Week High 8.46 | 52 Week Low 0.25 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CYTO Daily Charts |
CYTO Intraday Charts |
Whats New @ Bazaartrend |
CYTO Free Analysis |
|
|
CYTO Important Levels Intraday
| RESISTANCE | 0.87 |
| RESISTANCE | 0.84 |
| RESISTANCE | 0.82 |
| RESISTANCE | 0.80 |
| SUPPORT | 0.74 |
| SUPPORT | 0.72 |
| SUPPORT | 0.70 |
| SUPPORT | 0.67 |
CYTO Forecast May 2024
| 4th UP Forecast | 2.29 |
| 3rd UP Forecast | 1.8 |
| 2nd UP Forecast | 1.5 |
| 1st UP Forecast | 1.2 |
| 1st DOWN Forecast | 0.34 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -0.26 |
| 4th DOWN Forecast | -0.75 |
CYTO Weekly Forecast
| 4th UP Forecast | 2.77 |
| 3rd UP Forecast | 2.13 |
| 2nd UP Forecast | 1.73 |
| 1st UP Forecast | 1.34 |
| 1st DOWN Forecast | 0.20 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.59 |
| 4th DOWN Forecast | -1.23 |
CYTO Forecast2024
| 4th UP Forecast | 16.96 |
| 3rd UP Forecast | 11.77 |
| 2nd UP Forecast | 8.56 |
| 1st UP Forecast | 5.35 |
| 1st DOWN Forecast | -3.81 |
| 2nd DOWN Forecast | -7.02 |
| 3rd DOWN Forecast | -10.23 |
| 4th DOWN Forecast | -15.42 |
Auris Medical Holding Ltd ( NASDAQ USA Symbol : CYTO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYTO Business Profile
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in Phase 2 of clinical development for the intranasal treatment of vertigo; Keyzilen, which is in Phase 3 of clinical development for the treatment of acute inner ear tinnitus; and Sonsuvi that is in Phase 3 of clinical development for the treatment of acute inner ear hearing loss. It operates primarily in Basel, Switzerland. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda. Address: Clarendon House, Hamilton, Bermuda, HM 11
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service